Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics of pioglitazone and to
determine the effect on inflammatory biomarkers for pioglitazone in patients with severe
sepsis and septic shock.